PGY-2 Infectious Diseases Residency

The Infectious Diseases pharmacy residency at the Medical University of South Carolina is a specialized residency consisting of 12 months of training and experience in various practice areas in infectious diseases including antimicrobial stewardship and immunocompromised hosts. The program allows sufficient flexibility to adapt to the interests and needs of the individual resident, yet provides the basic foundation for quality clinical practice in infectious diseases. The resident will have the opportunity to gain clinical, research, and teaching experience in infectious diseases. Upon completion of this comprehensive program, the resident will be prepared to enter a clinical practice position or a fellowship program.

The Postgraduate Year Two (PGY2) Infectious Diseases Pharmacy Residency Program is designed to develop accountability; practice patterns; habits; and expert knowledge, skills, attitudes, and abilities in the respective advanced area of pharmacy practice. The Infectious Diseases Pharmacy Residency Program builds upon the broad-based competencies achieved in a PGY1 residency, deepening the resident's ability to provide care in the most complex of cases or in the support of care through practice leadership. Therefore, the Infectious Diseases Pharmacy Residency Program provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and transforming both into improved medication therapy for patients. A resident who successfully completes the PGY2 Infectious Diseases Pharmacy Residency Program should be prepared to enter into a clinical practice position in a hospital-based environment or a combination of academia and practice affiliated with a College of Pharmacy. They should also possess the competencies that enable attainment of board certification in the practice area (i.e., Board Certified Infectious Diseases Pharmacist).

Specific residency goals and objectives will be established in the beginning of the residency modified according to the resident's interests and previous experiences and advisor input. To meet the purpose of the residency, the resident will advance to achieve the following outcomes:

  • Serve as an authoritative resource on the optimal use of medications in patients with infectious diseases.
  • Optimize the outcomes of infections diseases patients by promoting and/or providing evidence-based medication therapy as an integral member of an interdisciplinary team in acute and ambulatory care settings.
  • Optimizing clinical outcomes while minimizing unintended consequences of antimicrobial use through antimicrobial stewardship.
  • Manage and improve the medication-use process in patients with known or suspected infectious diseases.
  • Demonstrate leadership and practice management skills.
  • Demonstrate excellence in the provision of training or educational activities about anti-infective agents for health care professionals and health care professionals in training.
  • Conduct research and contribute to the medical literature in the infectious diseases arena.
  • Contribute to formulary decisions regarding anti-infective agents and participate on the Anti-infective Subcommittee of the Pharmacy and Therapeutics Committee.
  • Demonstrate skills required to function in an academic setting.

The resident will have the opportunity to gain clinical, research, and teaching experience in infectious diseases. The breadth of experience provided by this residency program will allow successful candidates to work in any facet of infectious diseases. The residency is designed to provide a diverse experience, while focusing on the needs of the individual resident. Residents may tailor elective rotations to meet their particular goals and career needs. In addition to month-long rotations, residents will have several longitudinal experiences including staffing, HIV/ID clinic, and adult on-call. The adult on-call experience is a 24-hour program that allows for PGY2 residents to refine their knowledge base and become proficient in, but not limited to, the following areas: time management, drug information search strategies and literature evaluation, communication, pharmacokinetics, and antibiotic initiation and follow up. Residents are provided with formal written evaluations following each monthly rotation in order to provide for an optimal experience. Residents will complete a quarterly self-evaluation to assure compliance with self-determined goals and the ASHP Residency Learning System. The resident must have previously completed a pharmacy practice residency or have an equivalent level of experience in hospital pharmacy practice prior to entering this specialized residency program.

Rotations

Required core rotations for 1 to 3 months are available in the following areas:

Adult Infectious Diseases Consult Service - 3 months
Antimicrobial Stewardship Service - 2-3 months
Infectious Diseases (HIV) Clinic - 11 months (longitudinal)
Microbiology Lab - 1 month
Electives* - 3-4 month

*Electives include, but are not limited to, the following month long rotations:

  • Medical Intensive Care
  • Pediatric Infectious Diseases Consult Service
  • Pulmonary Medicine
  • Transplant Infectious Disease Service
  • Medication Use Policy and Informatics
  • Emergency Medicine

Core Disease-specific Index

  • Bone and joint infections
  • Cardiovascular infections
  • Central nervous system infections
  • Fever of unknown origin
  • Fungal infections
  • Gastrointestinal infections
  • Hepatitis B
  • Hepatitis C
  • HIV-infection and AIDS
  • Intra-abdominal infections
  • Neutropenic fever
  • Ophthalmologic infections
  • Opportunistic infections in immunocompromised hosts
  • Parasitic infections
  • Reproductive organ infections
  • Respiratory infections: upper and lower
  • Rickettsial infections
  • Sepsis
  • Sexually transmitted diseases
  • Skin and soft tissue infections
  • Tuberculosis and other mycobacterial Infections
  • Travel medicine
  • Urologic infections
  • Viral infections.
  • Krutika N. Mediwala, PharmD, BCPS, BCIDP; Clinical Pharmacy Specialist, Infectious Diseases/Antimicrobial Stewardship; Affiliate Assistant Professor
  • Brian R. Raux, PharmD, BCPS, BCIDP; Clinical Pharmacy Specialist, Infectious Diseases/Antimicrobial Stewardship; Affiliate Assistant Professor
  • Joseph Mazur, PharmD, BCPS, BCNSP; Clinical Manager; Clinical Pharmacy Specialist, MICU; Clinical Assistant Professor; Residency Program Director for Critical Care
  • Wendy Bullington, PharmD, BCPS; Clinical Pharmacy Specialist, Pulmonary/ Emergency Medicine; Clinical Assistant Professor; Residency Program Director for Pharmacotherapy; Medicine Clinical Coordinator
  • Lisa Steed. Ph.D.; Director, Clinical Microbiology Laboratory; Professor; Pathology and Laboratory Medicine
  • Genevieve Hayes, PharmD, MS, BCPS; Manager, Medication Use Policy and Informatics; Clinical Assistant Professor
  • Amanda L. Parks, MD; Assistant Professor, Department of Infectious Diseases, College of Medicine
  • John W. Gnann Jr., MD; Professor, Department of Infectious Diseases, College of Medicine
  • Terry R. Dixon, MD, PhD; Assistant Professor, Department of Pediatrics.

Teaching certificate programming available through the Academic Preparation Program (APP).

  • Didactic lectures in infectious diseases related areas within the college of pharmacy.
  • In-services to pharmacy, medical, and nursing staff (inpatient and outpatient).
  • Co-preceptor of PharmD students and PGY1 residents on rotations.
  • All PGY2 residents have their PGY1 residency certificate on file.
  • As is applicable to the specific residency program, residents will complete the ACLS/PALS curriculum and participate in medical emergencies.
  • Attain an “achieved” on 95% of the RLS objectives as assessed by the RPD on the last quarterly evaluation (June).
    No NI’s may be present upon graduation of the program.
  • If participating, complete all requirements of the Academician Preparation Program (APP)
  • Complete all assigned evaluations
  • Complete end-of-year self-assessment and review with RPD.
  • Participate in medication use evaluation(s). Provide a written document with methods, findings, and recommendations.
  • Complete a service or research project designed to improve the services of the Pharmacy ICCE. Prepare a manuscript suitable for publication in a peer-reviewed biomedical journal. Editorial assistance by the preceptor is required.
  • Prepare and present an ACPE-approved continuing education seminar.
  • Complete all Pharmacy On-call Service requirements as assigned.
  • Complete all staffing requirements as assigned.
  • Present research/MUE project at an approved local, national, regional or state meeting.
  • Evaluate 4 Grand Rounds presentations throughout the year.

PGY2 Specific:

  • Establish competency in Core Disease-specific Indec
  • Prepare and present educational content for the Infectious Diseases department
  • Participate in ID-related professional development